Explore how payers and providers collaborate to enhance value-based care, tackle rising costs, and improve patient outcomes ...

Jenny Craven, PharmD, BCPS, outlines the strategies UC Davis Health has used to successfully navigate the complex challenges of implementing cell and gene therapies.

A UK cohort study finds socioeconomic deprivation in early life is tied to greater eating disorder symptoms in adolescence, with barriers to care.

Lauren Wisk, PhD, discusses the implications of an all-inclusive long COVID definition and its application in clinical practices.

The author discusses how Principal Care Management (PCM) enhances oncology care, improves patient outcomes, and boosts ...

A novel image-based deep learning approach achieves high accuracy and interpretability, offering potential for clinical ...

Deepak L. Bhatt, MD, MPH, MBA, of Mount Sinai Fuster Heart Hospital, spoke at the recent ASPC 2025 Congress on CVD Prevention ...

FDA approved zopapogene imadenovec, the first therapy for recurrent respiratory papillomatosis, providing an option beyond ...

National Psoriasis Awareness Month offers an opportunity to examine how advances in systemic therapy, combined with ...

Given the track record of good outcomes and savings, policy leaders must do more to promote growth of for-profit PACE ...

Today, the FDA issued a complete response letter (CRL) for vatiquinone (PTC Therapeutics), delaying its potential approval as a treatment for Friedreich ataxia amid efficacy concerns.

Definitive conclusions regarding the association between semaglutide and nonarteritic anterior ischemic optic neuropathy could not be established.